Risk factors for cataracts in systemic lupus erythematosus (SLE)

被引:28
|
作者
Alderaan, Khaled [1 ,2 ]
Sekicki, Vuk [3 ]
Magder, Laurence S. [4 ]
Petri, Michelle [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD 21205 USA
[2] King Fahad Specialist Hosp, Rheumatol Sect, Dammam, Saudi Arabia
[3] St Agnes Hosp, Dept Internal Med, Baltimore, MD 21229 USA
[4] Univ Maryland, Baltimore, MD 21201 USA
关键词
Cataract; Predictor; Frequency; Systemic lupus erythematosus; POSTERIOR SUBCAPSULAR CATARACTS; AGE-RELATED CATARACT; BLUE MOUNTAINS EYE; RHEUMATOID-ARTHRITIS; CIGARETTE-SMOKING; REVISED CRITERIA; LENS OPACITIES; BLOOD-PRESSURE; CORTICOSTEROIDS; NUCLEAR;
D O I
10.1007/s00296-014-3129-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cataract is the most common ocular damage in systemic lupus erythematosus (SLE). We analyzed data from the Hopkins Lupus Cohort longitudinally to identify the factors that predict onset of cataract prior to 60 years of age. The Hopkins Lupus Cohort is a clinical cohort of patients with SLE seen quarterly. This analysis was based on the follow-up experience prior to age 60 of 2,109 SLE patients who had not had a cataract prior to cohort entry. Patients saw their ophthalmologist every 6 months. Cataract was defined by the SLICC/American College of Rheumatology Damage Index. The rate of incident cataract was calculated in subsets of the follow-up defined by patient characteristics and history. Multivariable logistic regression models were fit to identify predictors of cataract while controlling for potential confounding variables. The analysis was based on 11,887 persons-years of follow-up, with median follow-up time of 4.1 years per patient. The incidence of cataract was 13.2/1,000 persons-years. Adjusting for other predictors, a cumulative prednisone dose equivalent to 10 mg/day for 10 years was a strong predictor of cataract (RR = 2.9, P = 0.0010). Disease activity measured by SELENA-SLEDAI (P = 0.0004) and higher systolic blood pressure (P = 0.0003) were associated with cataract. Duration of SLE, diabetes mellitus, smoking, cholesterol, renal involvement, immunological profile and medication history other than prednisone were not associated with cataract. Cataract development in SLE patients is multifactorial with prednisone, systolic blood pressure and disease activity all playing a role.
引用
收藏
页码:701 / 708
页数:8
相关论文
共 50 条
  • [1] Risk factors for cataracts in systemic lupus erythematosus (SLE)
    Khaled Alderaan
    Vuk Sekicki
    Laurence S. Magder
    Michelle Petri
    Rheumatology International, 2015, 35 : 701 - 708
  • [2] Risk factors for cataracts in a cohort of Egyptian systemic lupus erythematosus patients
    El Sherbiny, Dalia A.
    El Shereif, Radwa
    EGYPTIAN RHEUMATOLOGIST, 2020, 42 (02) : 113 - 116
  • [3] Fibromyalgia, Systemic Lupus Erythematosus (SLE), and Evaluation of SLE Activity
    Wolfe, Frederick
    Petri, Michelle
    Alarcon, Graciela S.
    Goldman, John
    Chakravarty, Eliza F.
    Katz, Robert S.
    Karlson, Elizabeth W.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (01) : 82 - 88
  • [4] Hydroxychloroquine in systemic lupus erythematosus (SLE)
    Ponticelli, C.
    Moroni, G.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (03) : 411 - 419
  • [5] Risk factors for cytomegalovirus disease in systemic lupus erythematosus (SLE): a systematic review
    Choo, Hui Min Charlotte
    Cher, Wen Qi
    Kwan, Yu Heng
    Fong, Warren Weng Seng
    ADVANCES IN RHEUMATOLOGY, 2019, 59 (1) : 12
  • [6] Risk factors for osteonecrosis in systemic lupus erythematosus
    Mont, MA
    Glueck, CJ
    Pacheco, IH
    Wang, P
    Hungerford, DS
    Petri, M
    JOURNAL OF RHEUMATOLOGY, 1997, 24 (04) : 654 - 662
  • [7] A prospective study of obesity and risk of systemic lupus erythematosus (SLE) among Black women
    Cozier, Yvette C.
    Barbhaiya, Medha
    Castro-Webb, Nelsy
    Conte, Carolyn
    Tedeschi, Sara
    Leatherwood, Cianna
    Costenbader, Karen H.
    Rosenberg, Lynn
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 48 (06) : 1030 - 1034
  • [8] Profile of cardiovascular risk factors in patients with systemic Lupus erythematosus: The CArdiovascular Risk Assessment STudy in Lupus erythematosus (CASTLE SLE) study
    Fox, H.
    Jung, O.
    Bartel, C.
    Hauser, I. A.
    Ehrlich, J. R.
    JOURNAL FUR KARDIOLOGIE, 2018, 25 (5-6): : 128 - 134
  • [9] Subelinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype
    Ahmad, Y.
    Shelmerdine, J.
    Bodill, H.
    Lunt, M.
    Pattrick, M. G.
    Teh, L. S.
    Bernstein, R. M.
    Walker, M. G.
    Bruce, I. N.
    RHEUMATOLOGY, 2007, 46 (06) : 983 - 988
  • [10] Fall Risk and Related Factors in Systemic Lupus Erythematosus
    Melikoglu, Meltem Alkan
    Bagcier, Fatih
    ARCHIVES OF RHEUMATOLOGY, 2017, 32 (03) : 216 - 220